China (Mainland)
Diamondsupplier 
Factory supply Latanoprost powder CAS 130209-82-4 CAS NO.130209-82-4
- FOB Price: USD: 300.00-300.00 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,MoneyGram
- Available Specifications:
USP(50-100)Gram
- Product Details
Keywords
- latanoprost
- 130209-82-4
- latanoprost powder
Quick Details
- ProName: Factory supply Latanoprost powder CAS ...
- CasNo: 130209-82-4
- Molecular Formula: C26H40O5
- Appearance: yellow oil liquid
- Application: eye drops
- DeliveryTime: in 7 days
- PackAge: 1G/vial or as your requirement
- Port: Shanghai/Beijing/Xiamen/Tianjin
- ProductionCapacity: 1000 Kilogram/Year
- Purity: 99%
- Storage: 2~8℃
- Transportation: 2~8 ℃ by adding blue ice
- LimitNum: 1 Gram
- Related Substances: 0.1%
- Residue on Ignition: 0.5%
- Heavy Metal: 10ppm
- Valid Period: 2 years
- appearance: yellow oil liquid
Superiority
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Basic information of Latanoprost
| Product name | Latanoprost |
| CAS | 130209-82-4 |
| Appearance | Yellow oil liuqd |
Details
1. Company Profile:
SINOWAY INDUSTRIAL CO.,LTD is a state-owned company and a professional supplier in exporting Pharmaceutical Raw and its intermediates, Cosmetic Raw Material, Healthcare Product from China since 1987, about 34 years experiences to Europe, America and Southeast Asia. We have gained very good reputation from all our customers in the world.Custom manuafacturing is very strong from us.We have developed some new items together with our local universityand institute special for our oversea clients for long term business under signing secret agreement.
2. The COA of Latanoprost
3. Use of Latanoprost
Latanoprost eye drops are colorless, clear liquid.Latanoprost eye drops are used to reduce intraocular pressure in patients with open-angle glaucoma and high intraocular pressure
